Skip to main content

Dezawa MUSE Stem Cell Treatment For Shoulder Pain: Clinical Report Released

Lydian Cosmetic Surgery Clinic has published new information on Dezawa MUSE stem cell therapy for shoulder pain, highlighting high success rates among patients and several high-profile endorsements.

-- The new report showcases extremely promising performance metrics emerging from the scientific community, demonstrating a rate of cellular homing 14% higher than non-MUSE alternative treatments. These performance metrics underscore the potential of regenerative medicine to offer non-surgical alternatives backed by scientific evidence for individuals suffering from chronic shoulder pain.

More information is available at https://www.lydianclinic.com/blog/kim-kardashian-dezawa-muse-stem-cell-for-shoulder-pain/

MUSE cells, or Multilineage-differentiating Stress Enduring cells, were developed by Professor Mari Dezawa in Japan and represent a distinct class of stem cells. Naturally occurring in the human body, these cells possess the ability to differentiate into multiple tissue types across all three germ layers—including nerve, muscle, bone, and cartilage—while maintaining a low risk of tumor formation.

The informational article published by Lydian Cosmetic Surgery Clinic documents how Dezawa MUSE stem cell treatment enables damaged shoulder tissue to be directly repaired and regenerated at a cellular level, rather than merely managed symptomatically. Clinics offering the therapy emphasize that MUSE cells integrate into injured areas and transform into the specific cell types needed for repair, often without requiring extensive tissue matching for donor cells.

The guide also highlights high-profile associations with the therapy; Kim Kardashian, most notably, has expressed ongoing interest in regenerative treatments like MUSE cells, and continues to advocate for their use. Mel Gibson, Tiger Woods, and Kobe Bryant are also all documented users of stem cell treatments for regenerative and injury recovery purposes.

The therapy is known to have a high safety profile due to the naturally occurring, non-tumorigenic characteristics of MUSE cells, which carry lower risk profiles and shorter down times compared to other stem cell approaches. Suitable candidates include individuals with chronic shoulder pain from overuse, aging, or mild to moderate degeneration—particularly those seeking to avoid surgery or who are not ideal surgical candidates.

Lydian Cosmetic Surgery Clinic positions itself as a qualified provider of Dezawa MUSE stem cell therapy, with expertise in regenerative medicine and a commitment to patient safety. The new report is now publicly available on their website, and the clinic invites individuals suffering from chronic shoulder pain to consult with medical professionals to determine candidacy for this non-surgical treatment option; professional medical evaluation remains necessary to assess individual suitability and expected outcomes.

For more details, visit https://www.lydianclinic.com/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89182475

Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  242.91
+3.60 (1.51%)
AAPL  269.95
+10.47 (4.04%)
AMD  246.27
+9.54 (4.03%)
BAC  54.03
+0.83 (1.56%)
GOOG  344.84
+6.31 (1.86%)
META  706.41
-10.09 (-1.41%)
MSFT  423.37
-6.92 (-1.61%)
NVDA  185.61
-5.52 (-2.89%)
ORCL  160.06
-4.52 (-2.75%)
TSLA  421.90
-8.51 (-1.98%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.